This protocol is judged by an institutional critique board, an impartial group that evaluations any clinical trials involving humans. If a research consists of a Program I drug, as soon as the board approves the protocol as moral, the researchers really need to make an application for an investigational new drug (IND) amount in the FDA.Due to this